// App-Quantinova.ai

1879 : TRAIL Preferentially Affects Cell Cycle-Arrested Tumor Cells Including Stem- and Progenitor Cells From Patients with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Catarina Castro Alves

Principal Investigators

  • Franziska Wachter

  • Irmela Jeremias

Medical Centers

  • Department of Gene Vectors, Helmholtz Center Munich, Munich, Germany

  • Department of Gene Vectors, Helmholtz Center Munich, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • p53

Drug/Treatment

  • Caffeine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved